Skip to content

bit.bio raised $25 million in a series d round, announced Nov. 4.

Facts

Company
bit.bio
Amount
$25 million
Currency
USD
Stage
Series D
Announced
Nov 4, 2026

Investors

Use of funds

Expand its portfolio of human cell types and make its models more widely available to researchers.

As stated by the company.

Sources

  1. 1.Human cell programming company bit.bio closes $25M Series D — Tech.eu, Nov 4, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Nov 4, 2026